Purchase Order 75N93019P00669

The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $49,710 purchase order to Maxcyte, Inc. of Potomac, Maryland under a firm fixed price contract. The contract is for the delivery of a Maxcyte E-ATX Cell Processor to support the NIH/NIAID's research efforts through September 15, 2023. As the prime contractor, Maxcyte will provide its cell processing equipment without support from major subcontractors. The...

The U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), awarded a one-year, firm-fixed-price purchase order to Maxcyte, Inc. for the lease of one MaxCyte® GT Flow Transfection System, valued at $100,000.00. The equipment will be used to support biomedical research at the agency's facilities in Bethesda, Maryland. This award is not associated with a larger contract vehicle and does not utilize a set-aside designation. Maxcyte, Inc. is...

The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order contract to Maxcyte, Inc., a small business, for the procurement of a MaxCyte ATX Scalable Transfection System with software licenses. The contract has a potential value of $50,069.70 and was awarded on March 18, 2019 with a completion date of June 2, 2019. The award was made on a sole-source basis under the...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation for $19,760.00 on June 21, 2019, with ultimate completion on July 21, 2019. Place of performance is Bethesda, Maryland. The order covers laboratory supplies and consumables, priced on a firm fixed price basis with no set-aside designation.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to the State of Maryland for $9,750.00 on August 22, 2017, for biological material. Performance is located in Baltimore, Maryland, with an ultimate completion date of September 21, 2017. The order is firm fixed-price with no set-aside designation.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to the State of Maryland for biomaterial on August 22, 2017, with a ceiling value of $4,875.00 and an ultimate completion date of September 21, 2017. Performance occurs in Baltimore, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Molecular Devices LLC on July 29, 2019, for $48,522.00 in consumables on a firm fixed-price basis. Place of performance is San Jose, California. The order completed on August 28, 2019. The pre-solicitation was posted July 15, 2019, with a due date of July 25, 2019.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Miltenyi Biotec, Inc. on September 13, 2018 for Illumina cell isolation and labelling kits with a ceiling value of $15,424.25.</p> <p>Performance is located in Auburn, California. The order carries a firm fixed-price structure with an ultimate completion date of October 31, 2018. No set-aside applies to this acquisition.</p>

This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Maxcyte, Inc. The contract is for the provision of an EXPERT STX SCALABLE TRANSFECTION SYSTEM, a specialized laboratory technology, to support the agency's biomedical research mission. The contract has a ceiling value of $107,300.00 and a period of performance through September 20, 2024. Maxcyte, Inc. is a...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Eppendorf North America, Inc. for $14,997.00 on July 11, 2019, with an ultimate completion date of August 30, 2019. Performance will take place in Bethesda, Maryland. The order is firm fixed price with no set-aside applied. Specific requirements for the purchase are not detailed in the source documentation.</p>